drugset / Trial / NCT01913808

Comparing Intravenous and Oral Iron in Postoperative Anemia

NCT01913808

Phase 4 Completed 122 enrolled Parc de Salut Mar Vifor Pharma · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Postoperative anaemia are common in patients undergoing major orthopaedic surgery. The main consequence of perioperative anaemia is an increased risk of red blood cell (RBC) transfusions. Allogeneic RBC transfusion and anaemia are associated with higher postoperative mortality and morbidity. The aim of this study was to compare the efficacy of postoperative i.v. ferric carboxymaltose (FCM) and oral ferrous glycine sulphate (FS) for early improvement of postoperative anaemia after total knee arthroplasty and whether iron treatment could facilitate recovery from surgery.

Timeline

Start
2011-01
Primary completion
2012-02
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified Intravenous
Comparator Ferrous Glycine Sulfate Unknown 100 mg Oral

Indications